What is the best tech stack for a clinical research site in 2027?

Direct Answer

The best tech stack for a clinical research site in 2027 is built around a site CTMS (clinical trial management system) — Clinical Conductor for large site networks or RealTime-CTMS / CRIO for single and mid-size sites — that runs the study, subject, and visit lifecycle; wired to an eRegulatory / eSource / eISF platform (Florence Healthcare or Veeva SiteVault) that carries the 21 CFR Part 11 burden and survives sponsor and FDA inspections; fed by a patient recruitment engine (SubjectWell, Antidote, or CRIO/Clinical Conductor's built-in pre-screening) because enrollment is the bottleneck that pays the bills; with data keyed into whatever sponsor-provided EDC the protocol mandates (Medidata Rave, Veeva CDMS, Oracle Clinical One); and study budgets, contracts, milestone invoicing, and participant payments tracked in the CTMS financial module plus Greenphire for stipend disbursement.

A research site is not an R&D lab. It does not discover compounds or run an ELN/LIMS. It conducts trials that other people designed: it recruits and consents humans, runs them through a protocol-defined visit schedule, captures source data, and bills the sponsor per milestone.

So the tech stack centers on three things a discovery lab never touches — a CTMS that orchestrates concurrent protocols, a Part 11-grade eRegulatory/eSource system that makes the site audit-ready, and a recruitment-to-payment pipeline that turns enrolled patients into collected revenue.

TL;DR

— Enrollment is the whole game: you get paid when subjects complete visits, so the tech stack is engineered around recruitment, retention, and milestone billing. A site CTMS runs the study/subject/visit lifecycle across many concurrent trials; an eReg/eSource/eISF platform makes you survive a sponsor or FDA inspection; sponsor-provided EDC is non-negotiable and protocol-dictated; and Greenphire-style payment rails plus CTMS financials close the loop from consent to cash.

Single sites can do this on RealTime-CTMS or CRIO plus Florence and QuickBooks; large SMOs run Clinical Conductor plus Veeva SiteVault plus a warehouse.

Why the Clinical Research Site Tech Stack Works Differently

1. The CTMS runs the study, subject, and visit lifecycle across many concurrent trials at once. A site is rarely running one protocol — it juggles a dozen or more sponsors, each with a different visit schedule, procedure list, and stipend structure. The site CTMS is the operational spine: it holds the protocol calendar, generates each subject's visit windows, tracks who is enrolled in what, flags overdue visits and missed procedures, and rolls every visit up to a billable event. Where a B2B company centers on a CRM and a discovery lab centers on an ELN, a research site centers on the CTMS, because the visit schedule *is* the business model.

1. eRegulatory, eSource, eISF, and 21 CFR Part 11 compliance are the audit-survival core. A site lives or dies by inspection. Sponsors monitor it, the FDA can inspect it, and a single uncontrolled document or unsigned source page triggers a finding that can shut down a study. The eRegulatory system holds the investigator site file (the eISF), version-controls every regulatory document, captures Part 11-compliant electronic signatures, and produces a clean audit trail on demand. ESource replaces paper source worksheets with structured, timestamped, signed electronic capture at the point of care. This layer is not a convenience — it is the difference between passing an audit and losing the trial.

1. Patient recruitment, pre-screening, and retention are the number-one bottleneck and the direct revenue driver. Roughly 80 percent of trials miss enrollment timelines, and an empty study pays nothing. Enrollment is literally how a site earns: sponsors pay per screened, per enrolled, and per completed visit. So the tech stack carries a recruitment engine — patient databases, advertising-driven funnels, text and email outreach, and pre-screening logic — plus retention tooling to keep enrolled subjects from dropping out before milestone completion. A site that can fill studies fast is a site sponsors send more work to.

1. Sponsor-provided EDC plus complex, deferred, per-visit payment collection define the financial reality. The site does not choose its EDC — each sponsor or CRO mandates the electronic data capture system (Medidata Rave, Veeva CDMS, Oracle Clinical One), and coordinators must enter data into a different platform for nearly every study. Meanwhile revenue arrives on a delay: budgets are negotiated per protocol, payments are tied to milestones and per-visit completion, holdbacks are common, and reconciling what the sponsor owes against what was actually performed is a constant grind. The financial layer must map performed visits to contracted line items and chase the gap.

The Core Stack, Layer by Layer

Site CTMS — Clinical Conductor by Advarra (alternates: RealTime-CTMS, CRIO, StudyManager). The operational system of record for protocols, subjects, visit calendars, and billable events. Clinical Conductor is the dominant enterprise site CTMS, built for multi-site networks that need centralized study oversight, financial tracking, and reporting across locations.

RealTime-CTMS is the strong mid-market choice with an excellent text-message recruitment and scheduling layer; CRIO is increasingly chosen because it fuses CTMS and eSource into one product, which removes a major integration headache for single and mid-size sites. Clinical Conductor runs roughly $2,000-$6,000+/month depending on site count and modules; RealTime-CTMS lands around $1,000-$3,000/month; CRIO is typically quoted per-site/per-study and runs a few hundred to a couple thousand per site/month.

eRegulatory / eSource / eISF — Florence Healthcare (alternates: Veeva SiteVault, CRIO eSource, RealTime-eSource). This is the Part 11 compliance core. Florence Healthcare's eBinders is the most widely deployed site-side eRegulatory and eISF platform, with eHub connecting the site to sponsors and CROs for remote document exchange and signature.

Veeva SiteVault is the strong alternate — a free-to-the-site eReg/eISF tier that plugs natively into the Veeva ecosystem sponsors increasingly use. If a site runs CRIO or RealTime as its CTMS, the matching eSource module keeps source capture in the same system. Florence runs roughly $300-$1,500/month per site by document and user volume; SiteVault's base eReg tier is free to sites, with paid eConsent and connected modules.

Patient recruitment & pre-screening — SubjectWell + CRIO/Clinical Conductor recruitment (alternates: Antidote, Clara Health, HubSpot + Twilio, Mautic). The enrollment engine. SubjectWell runs a managed, pay-per-randomized patient marketplace that feeds pre-qualified candidates into studies.

Antidote and Clara Health match patients to trials through condition-specific digital advertising. For sites that want to own the funnel, a marketing automation tool (HubSpot or open-source Mautic) drives ad-to-landing-page campaigns, and Twilio powers the SMS outreach and reminder sequences that drive show rates.

The built-in recruitment and pre-screening modules in CRIO and Clinical Conductor track every lead from first contact to consent. SubjectWell is usually pay-per-enrollment; HubSpot Marketing runs $800-$3,600/month at scale; Twilio is usage-based pennies per message.

Sponsor-provided EDC — Medidata Rave / Veeva CDMS / Oracle Clinical One (site does not choose). Electronic data capture is supplied by the sponsor or CRO, and coordinators enter trial data into whatever the protocol dictates. Medidata Rave is the most common EDC a site will touch, with Veeva CDMS and Oracle Clinical One close behind.

The site's cost here is training and login management across many systems, not licensing — but eSource-to-EDC reconciliation (entering source data once, then keying it again into the sponsor's EDC) is the daily reality, which is exactly why an eSource layer that exports cleanly matters.

e-Consent — Florence eConsent / Veeva SiteVault eConsent (alternate: CRIO eConsent). Electronic informed consent with Part 11 signatures, version control tied to the current IRB-approved form, and a clean trail of who consented to which version when. Often a module of the eReg platform already in place; budget roughly $100-$500/month per site when licensed separately.

Study payments & participant stipends — Greenphire (alternates: Mural Health, CTMS financial module). Greenphire's ClinCard is the standard rail for paying participants their per-visit stipends and reimbursing travel without the site fronting cash or cutting checks. Mural Health is the newer challenger.

The CTMS financial module handles the other side — site invoicing to the sponsor against milestones. Greenphire is typically funded per-study by the sponsor; the site pays for the CTMS financial module as part of its CTMS license.

Regulatory / IRB submission — Advarra IRB / WCG IRB. Central IRB review and submission for studies that use one. Advarra and WCG are the two dominant central IRBs; submission and review fees are study-specific and usually pass through to the sponsor.

Accounting & finance — QuickBooks Online (alternate: Sage Intacct). General ledger, payroll, and AR/AP for the site as a business. QuickBooks Online ($90-$200/month) fits single and mid-size sites; large SMOs move to Sage Intacct (~$10,000+/year) for multi-entity consolidation and revenue recognition that matches deferred milestone billing.

Business intelligence — Microsoft Power BI (alternate: native CTMS dashboards). Cross-study reporting on enrollment velocity, screen-fail rates, payment aging, and site utilization. Power BI ($14/user/month) reads from the CTMS and accounting export; smaller sites lean on the CTMS's built-in dashboards and skip a separate BI tool.

Real Operators & What They Run

• Velocity Clinical Research (large multi-therapeutic site network) — runs an enterprise site CTMS (Clinical Conductor-class) centrally across its owned and integrated sites, standardizes eRegulatory and eSource on a single platform so every location passes inspection the same way, and operates a centralized recruitment and patient-database function that feeds enrollment across the network. Sponsor EDC varies study by study; financials and milestone invoicing roll up to a multi-entity accounting system with a warehouse and BI layer on top.

• Headlands Research (acquisitive site network / SMO) — standardizes acquired sites onto a common CTMS and eReg backbone to make integration and oversight tractable, layers central recruitment and a shared patient database over local sites, and uses Greenphire-style payment rails network-wide so participant stipends are uniform. The hard problem is migrating each acquired site's legacy paper or mismatched systems onto the network standard.

• A regional multi-site research group (3-8 dedicated sites) — runs RealTime-CTMS or Clinical Conductor across its locations with Florence eBinders for eRegulatory, adds a recruitment platform like SubjectWell plus its own HubSpot/Twilio funnel, uses Greenphire for participant payments, and reports enrollment and payment aging in Power BI. QuickBooks or Sage Intacct handles the books.

• A single-site dedicated research center — typically runs CRIO (CTMS plus eSource in one) or RealTime-CTMS with Florence for eReg, keeps recruitment in the CTMS's built-in module plus targeted Facebook ads, enters sponsor data into whatever EDC each protocol mandates, and runs the business on QuickBooks Online. Lean, integrated, and inspection-ready without an enterprise budget.

• A hospital or academic medical center research site — sits inside an Epic EHR and a university grants/compliance environment, often runs an institutional CTMS (OnCore is common in academia) for protocol and financial tracking, uses the institution's IRB rather than a central one, and reconciles study billing against the hospital's clinical billing to avoid double-billing Medicare for research-related procedures.

• A private-practice clinic running trials on the side — a cardiology or dermatology group that conducts a handful of studies adjacent to its clinical practice. It runs a light CTMS (CRIO or RealTime), Florence or SiteVault for eReg, leans on sponsor recruitment support and its own patient panel, and keeps the trial books separate from the practice's clinical revenue in QuickBooks.

Integration Architecture

The CTMS is the hub. Recruitment funnels candidates into it; the visit calendar drives eSource capture at each visit; source data reconciles into the sponsor's EDC; the eRegulatory/eISF system runs alongside as the compliance backbone; and every completed visit becomes a billable line that flows through CTMS financials to the sponsor and through Greenphire to the participant.

Failure Modes

1. Buying an enterprise CTMS a single site can't staff. Clinical Conductor is built for networks. A two-coordinator site that licenses it often drowns in configuration and ends up using ten percent of it while still entering data in spreadsheets. The fix is matching CTMS to scale — CRIO or RealTime for single and small sites — and only moving to an enterprise CTMS when multi-site oversight genuinely demands it.

1. Treating eRegulatory as document storage instead of an inspection system. Sites that dump PDFs into a shared drive or a generic eReg tool without version control, signature trails, and current-IRB-form binding fail inspections on document control. The fix is a purpose-built eISF (Florence or SiteVault) with enforced versioning, Part 11 signatures, and a real audit trail — and actually using its workflow rather than working around it.

1. No recruitment engine, so studies enroll slow and sponsors stop sending work. Sites that rely only on their existing patient list under-enroll, miss timelines, and quietly fall off sponsor site-selection lists. The fix is an actual funnel — a recruitment marketplace like SubjectWell plus an owned ad-to-landing-page-to-SMS pipeline — and tracking screen-to-enroll conversion as a core metric, not an afterthought.

1. Losing the milestone-to-payment reconciliation. Because payment is per-visit, deferred, and holdback-laden, sites that don't tie performed visits to contracted budget line items leave real money uncollected and can't tell which studies are actually profitable. The fix is using the CTMS financial module to map every completed visit to its budget line, run aging on what sponsors owe, and reconcile monthly — not at study close-out when the trail has gone cold.

Budget & Sizing

• Single research site (1-3 coordinators, a few concurrent studies). CRIO or RealTime-CTMS (CTMS + eSource), Florence or free Veeva SiteVault for eReg, built-in recruitment plus modest paid ads, QuickBooks Online, Greenphire funded by sponsors. Roughly $1,500-$4,000/month in owned software.

• Multi-site research group (3-8 sites, dedicated recruitment staff). Clinical Conductor or networked RealTime-CTMS, Florence eBinders standardized across sites, a recruitment platform (SubjectWell) plus a HubSpot/Twilio funnel, Greenphire network-wide, QuickBooks or Sage Intacct, and Power BI reporting. Roughly $5,000-$15,000/month.

• Large site network / SMO (10+ sites). Enterprise Clinical Conductor across all locations, Veeva SiteVault or Florence enterprise for eReg/eISF, centralized recruitment and a managed patient database, Greenphire at scale, Sage Intacct for multi-entity consolidation, and a data warehouse with Power BI. Roughly $20,000-$75,000+/month all-in, with patient-recruitment spend often the largest variable line.

30/60/90 Day Implementation Plan

• Days 0-30 — Foundation. Select and stand up the CTMS sized to your scale. Load every active protocol, build each study's visit calendar and procedure list, and import your current subject roster. Train coordinators on visit tracking before anything else, because the calendar is the spine the rest hangs on.

• Days 31-60 — Compliance and recruitment. Migrate the investigator site file into the eRegulatory platform, turn on Part 11 electronic signatures, and bind documents to current IRB-approved versions. In parallel, launch the recruitment engine — connect a marketplace like SubjectWell and stand up an ad-to-landing-page-to-SMS funnel via HubSpot and Twilio — and start measuring screen-to-enroll conversion.

• Days 61-90 — Financials and reporting. Configure CTMS financials so every completed visit maps to its contracted budget line, connect Greenphire for participant stipends, and set up sponsor milestone invoicing. Stand up Power BI (or the CTMS dashboards) for enrollment velocity, screen-fail rate, and payment aging so leadership can see study profitability in near real time.

FAQ

Do I really need a CTMS, or can a single site run on spreadsheets and the sponsor's EDC? You need a CTMS the moment you run more than one or two concurrent studies. Spreadsheets cannot reliably generate visit windows, flag overdue visits, or tie completed visits to billable milestones across protocols — and the sponsor's EDC only holds trial data, not your operational and financial picture.

A right-sized CTMS like CRIO or RealTime pays for itself the first time it catches a missed visit window or an uninvoiced milestone.

What is the difference between a research site stack and a biotech/life-sciences lab stack? A discovery lab runs R&D — it generates new data with an ELN (electronic lab notebook) and a LIMS to manage samples and experiments. A research site runs trials other people designed: it recruits and consents patients, executes a protocol's visit schedule, and bills per milestone.

The site stack centers on CTMS, eRegulatory/eSource, recruitment, and milestone billing — none of which a discovery lab touches.

Why can't I pick my own EDC? Because the sponsor or CRO that owns the study mandates it. Each protocol specifies the EDC (Medidata Rave, Veeva CDMS, Oracle Clinical One), and your coordinators enter data into whatever that study requires. Your job is to manage logins and training across many EDCs and to capture clean source data — ideally in an eSource system — so re-keying into the sponsor's EDC is fast and error-free.

How do eRegulatory and eSource keep me inspection-ready? The eRegulatory system holds your investigator site file with enforced version control, Part 11-compliant signatures, and a complete audit trail, so when a sponsor monitor or the FDA asks for a document, you produce the current, signed version instantly.

ESource captures visit data electronically at the point of care with timestamps and signatures, eliminating the lost or illegible paper worksheets that generate the most common inspection findings.

How do participant payments and sponsor payments actually flow? Two separate rails. Participants get per-visit stipends and travel reimbursement through a platform like Greenphire's ClinCard, so the site never fronts cash or cuts checks. The sponsor pays the site against negotiated milestones and completed visits — usually deferred, often with holdbacks — which the CTMS financial module tracks by mapping each performed visit to its contracted budget line and running aging on what's owed.

Should a single site start with Clinical Conductor or CRIO? A single site almost always starts with CRIO or RealTime-CTMS, not Clinical Conductor. CRIO bundles CTMS and eSource into one product, which removes a costly integration and fits a small team's staffing and budget. Clinical Conductor is the right choice once you operate multiple sites and need centralized oversight, network reporting, and multi-entity financials — capabilities a single site can't fully use.

Sources

• Advarra — Clinical Conductor site CTMS product documentation and pricing guidance (2026)
• RealTime Software Solutions — RealTime-CTMS and RealTime-eSource feature and pricing overview (2025-2026)
• CRIO — combined CTMS and eSource platform documentation for research sites (2026)
• Florence Healthcare — eBinders eRegulatory, eISF, eHub, and eConsent product materials (2026)
• Veeva Systems — SiteVault eRegulatory and eConsent for sites, and Vault CDMS overview (2026)
• Greenphire — ClinCard participant payment and site reconciliation platform documentation (2025-2026)
• SubjectWell — patient recruitment marketplace and pay-per-enrollment model overview (2026)
• FDA — 21 CFR Part 11 electronic records and electronic signatures guidance for clinical sites (2025-2027)
• Medidata, Oracle, and Veeva — sponsor-provided EDC (Rave, Clinical One, CDMS) site-user documentation (2026)